These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8798164)

  • 1. Physical specifications of clinical proton beams from a synchrotron.
    Arduini G; Cambria R; Canzi C; Gerardi F; Gottschalk B; Leone R; Sangaletti L; Silari M
    Med Phys; 1996 Jun; 23(6):939-51. PubMed ID: 8798164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The M. D. Anderson proton therapy system.
    Smith A; Gillin M; Bues M; Zhu XR; Suzuki K; Mohan R; Woo S; Lee A; Komaki R; Cox J; Hiramoto K; Akiyama H; Ishida T; Sasaki T; Matsuda K
    Med Phys; 2009 Sep; 36(9):4068-83. PubMed ID: 19810479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced treatment planning methods for efficient radiation therapy with laser accelerated proton and ion beams.
    Schell S; Wilkens JJ
    Med Phys; 2010 Oct; 37(10):5330-40. PubMed ID: 21089768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A performance study of the Loma Linda proton medical accelerator.
    Coutrakon G; Hubbard J; Johanning J; Maudsley G; Slaton T; Morton P
    Med Phys; 1994 Nov; 21(11):1691-701. PubMed ID: 7891629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hadron therapy project].
    Amaldi U; Arduini G; Cambria R; Canzi C; Furetta C; Leone R; Rossi S; Silari M; Tosi G; Vecchi L
    Radiol Med; 1993 Nov; 86(5):669-79. PubMed ID: 8272553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation protection at Hadron therapy facilities.
    Pelliccioni M
    Radiat Prot Dosimetry; 2011 Jul; 146(4):407-13. PubMed ID: 21733860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle radiation therapy using proton and heavier ion beams.
    Schulz-Ertner D; Tsujii H
    J Clin Oncol; 2007 Mar; 25(8):953-64. PubMed ID: 17350944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy systems using proton and carbon beams.
    Jongen Y
    Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monte Carlo simulations to support start-up and treatment planning of scanned proton and carbon ion therapy at a synchrotron-based facility.
    Parodi K; Mairani A; Brons S; Hasch BG; Sommerer F; Naumann J; Jäkel O; Haberer T; Debus J
    Phys Med Biol; 2012 Jun; 57(12):3759-84. PubMed ID: 22617050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of physical dose distributions with hadron beams: comparing photon IMRT with IMPT.
    Oelfke U; Bortfeld T
    Technol Cancer Res Treat; 2003 Oct; 2(5):401-12. PubMed ID: 14529305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beam dumps design and local radiation protection at TERA synchrotron.
    Porta A; Campi F; Agosteo S
    Radiat Prot Dosimetry; 2005; 115(1-4):222-6. PubMed ID: 16381716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiobiological significance of beamline dependent proton energy distributions in a spread-out Bragg peak.
    Paganetti H; Goitein M
    Med Phys; 2000 May; 27(5):1119-26. PubMed ID: 10841418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental validation of the filtering approach for dose monitoring in proton therapy at low energy.
    Attanasi F; Belcari N; Camarda M; Del Guerra A; Moehrs S; Rosso V; Vecchio S; Lanconelli N; Cirrone GA; Di Rosa F; Russo G
    Phys Med; 2008 Jun; 24(2):102-6. PubMed ID: 18411070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical physics aspects of particle therapy.
    Jäkel O
    Radiat Prot Dosimetry; 2009 Nov; 137(1-2):156-66. PubMed ID: 19828718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-line monitoring of radiotherapy beams: experimental results with proton beams.
    Litzenberg DW; Roberts DA; Lee MY; Pham K; Vander Molen AM; Ronningen R; Becchetti FD
    Med Phys; 1999 Jun; 26(6):992-1006. PubMed ID: 10436901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities.
    Parodi K; Bortfeld T; Haberer T
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):945-56. PubMed ID: 18514787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practicability of protontherapy using compact laser systems.
    Malka V; Fritzler S; Lefebvre E; d'Humières E; Ferrand R; Grillon G; Albaret C; Meyroneinc S; Chambaret JP; Antonetti A; Hulin D
    Med Phys; 2004 Jun; 31(6):1587-92. PubMed ID: 15259663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric uncertainty in prostate cancer proton radiotherapy.
    Lin L; Vargas C; Hsi W; Indelicato D; Slopsema R; Li Z; Yeung D; Horne D; Palta J
    Med Phys; 2008 Nov; 35(11):4800-7. PubMed ID: 19070212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.